A vaccine designed to prevent and potentially treat triple-negative breast cancer is showing promise in human trials and ...

The at-home vaccine is the same as regular FluMist, which is approved for ages two through 49. That means babies and older ...

As confusion grows around COVID-19 access amid controversial moves by the CDC and FDA, states are taking matters into their ...

You can get FluMist for self-administration (called FluMist Home) by visiting the manufacturer’s website. You’ll need to ...

New guidelines limit shots to adults 65+ and those with underlying conditions, though Cleveland area pharmacies are making ...

The U.S. Food and Drug Administration's outside advisers will meet on Dec. 10 to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech for emergency use ...

Dr. Paul Offit, a frequent critic of US Health and Human Services Secretary Robert F. Kennedy Jr., has been blocked from participating in a panel of independent experts who advise the US Food and Drug ...

Peter Marks, the former top vaccine regulator at the U.S. Food and Drug Administration, has joined Eli Lilly, STAT News ...

Six months after his abrupt resignation as CBER director, Marks has been hired to run discovery and infectious disease work ...

The Trump administration is pushing for single-virus shots for measles, mumps, and rubella. It's an anti-vaccine talking ...

GLSI-100 has received FDA fast track designation for HLA-A*02-positive and HER2-positive breast cancer, expediting its development and review process. Preliminary data from the FLAMINGO-01 trial shows ...

Dr. Peter Marks, the former head of vaccine regulation for the Food and Drug Administration, has been hired by pharmaceutical ...